Aptose Biosciences Investor Relations Material

Aptose Biosciences Inc., a biotechnology company, discovers and develops personalized therapies addressing unmet medical needs in oncology primarily in the United States. In addition, the company is developing product candidates using Allogeneic Natural Killer Cell Pharmacological Chimeric Receptors (NK-PRRs) to treat cancer, with NK-PRR strategies designed to target specific tumor antigens. The company's mission is to deliver therapies that fit the precise characteristics of individual patients, by providing tailor-made, autologous treatments that harness a patient’s own immune system cells to fight disease.